Overall satisfaction increased more with inhaled insulin than with subcutaneous insulin in type 1 diabetes
- Differential Interactions of Nateglinide and Repaglinide on the Human Î²-Cell Sulphonylurea Receptor 1. Hansen, Ann Maria K.; Christensen, Inge T.; Hansen, John Bondo; Carr, Richard D.; Ashcroft, Frances M.; Wahl, Philip // Diabetes;Sep2002, Vol. 51 Issue 9, p2789
Repaglinide and nateglinide represent a new class of insulin secretagogues, structurally unrelated to sulphonylureas, that were developed for the treatment of type 2 diabetes. The inhibitory effect of these drugs was investigated on recombinant wild-type and mutant Kir6.2/SUR1 channels expressed...
- Intensive Insulin Therapy Reduces Counterregulatory Hormone Responses to Hypoglycemia in Patients with Type I Diabetes. Simonson, Donald C.; Tamborlane, Wiliam V.; DeFronzo, Ralph A.; Sherwin, Robert S. // Annals of Internal Medicine;Aug85, Vol. 103 Issue 2, p184
Presents a study that investigates the efficacy of intensive insulin therapy to reduce counterregulatory hormon responses to hypoglycemia in patients with type I diabetes. Methodology used in the study; Information on the patients; Discussion on the results.
- An Insulin Therapy Update. Sloane, Susan // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p231
The article offers information on the attributes and significance of insulin therapy on diabetic patients in the U.S.
- Insulin aspart. // Reactions Weekly;6/18/2011, Issue 1356, p22
The article describes the cases of two girls and one boy with type 1 diabetes mellitus who developed lipoatropathy while receiving insulin pump therapy with insulin aspart.
- Efficacy, Safety, and Pump Compatibility of Insulin Aspart Used in Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 1 Diabetes. Bode, Bruce W.; Strange, Poul // Diabetes Care;Jan2001, Vol. 24 Issue 1, p69
Provides information on a study which compared the efficacy, safety, and pump compatibility of insulin aspart in diabetics undergoing continuous subcutaneous insulin infusion therapy. Research design and methods; Results; Conclusions.
- Late-Onset Lipoatrophic Diabetes. Vantyghem, Marie-Christine; Vigouroux, Corinne // Diabetes Care;Aug99, Vol. 22 Issue 8, p1374
Reports a case of a patient with an acquired lipoatrophic diabetes (LD) whose endocrine and metabolic alterations were improved by treatment with metformin or lispro insulin analog. Findings during the clinical examination; Achievement for insulin therapy; Findings during the physical...
- Inpatient Management of Hyperglycemia and Diabetes. Seley, Jane Jeffrie // Diabetes Spectrum;Fall2008, Vol. 21 Issue 4, p230
The article discusses various reports published within the issue including one by Nancy J. D'Hondt on continuous intravenous insulin (CII) treatment for diabetes and another by Joyce Malaskovitz on the importance of data collection in efforts to enhance the quality of inpatient hyperglycemia and...
- Insulin therapy. Strowig, Suzanne; Robertson, Carolyn; Hurley, Mary Lou; Begany, Timothy // RN;Jun95, Vol. 58 Issue 6, p30
Discusses advances in insulin therapy in the treatment of type I diabetes. Intensive therapy; Rapid-acting insulin preparations; Intermediate; Long-acting; Pros and cons of conventional therapy; Four-injection regimen; Hypoglycemia; Intravenous insulin; Future of insulin delivery. INSETS:...
- A quick guide to insulin therapy. // RN;Jun95, Vol. 58 Issue 6, p35
Presents a guide to insulin therapy for type I diabetes. Proper injection technique; Dealing with hypoglycemia.
- INSULIN THERAPY. Strowig, Suzanne; Metules, Terri J. // RN;Sep2001, Vol. 64 Issue 9, p38
Intensive insulin therapy is aimed at mimicking natural hormonal secretion to optimize blood sugar control. Here's the latest on how new insulin preparations and delivery regimens may help accomplish this goal. INSETS: An alternative to daily injections.;A quick guide to insulin therapy..